Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys
E. Andrew Townsend, S. Stevens Negus, Justin L. Poklis, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107848-107848
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 181
A drug-vs-food “choice” self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders
E. Andrew Townsend, Kathryn L. Schwienteck, Hannah L. Robinson, et al.
Journal of Neuroscience Methods (2021) Vol. 354, pp. 109110-109110
Open Access | Times Cited: 43
Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder
Laura Brandt, Jermaine D. Jones, Suky Martinez, et al.
Drug and Alcohol Dependence (2020) Vol. 208, pp. 107859-107859
Open Access | Times Cited: 29
Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats
E. Andrew Townsend, Paul T. Bremer, Kaycee E. Faunce, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 9, pp. 1300-1310
Open Access | Times Cited: 29
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder
S. Stevens Negus, Matthew L. Banks
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1967-1973
Open Access | Times Cited: 23
A synthetic opioid vaccine attenuates fentanyl-vs-food choice in male and female rhesus monkeys
E. Andrew Townsend, Paul T. Bremer, Nicholas T. Jacob, et al.
Drug and Alcohol Dependence (2020) Vol. 218, pp. 108348-108348
Open Access | Times Cited: 22
Confronting the challenge of failed translation in medications development for substance use disorders
S. Stevens Negus, Matthew L. Banks
Pharmacology Biochemistry and Behavior (2021) Vol. 210, pp. 173264-173264
Open Access | Times Cited: 18
Medications Development for Treatment of Opioid Use Disorder
E. Andrew Townsend, S. Stevens Negus, Matthew L. Banks
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 1, pp. a039263-a039263
Open Access | Times Cited: 20
Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?
E. Andrew Townsend, Matthew L. Banks
CNS Drugs (2020) Vol. 34, Iss. 5, pp. 449-461
Open Access | Times Cited: 20
Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys
David R. Maguire, Lisa R. Gerak, Jesus J. Sanchez, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 12, pp. 1986-1993
Open Access | Times Cited: 20
Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats
E. Andrew Townsend, Bruce E. Blough, David H. Epstein, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 12, pp. 2132-2139
Open Access | Times Cited: 12
A Vaccine against Benzimidazole-Derived New Psychoactive Substances That Are More Potent Than Fentanyl
Jinny Claire Lee, Hyeri Park, Lisa M. Eubanks, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 2522-2531
Closed Access | Times Cited: 11
Improving Translational Research Outcomes for Opioid Use Disorder Treatments
Jermaine D. Jones, Neil B. Varshneya, Thomas J. Hudzik, et al.
Current Addiction Reports (2021) Vol. 8, Iss. 1, pp. 109-121
Open Access | Times Cited: 11
3,4-Methylenedioxypyrovalerone High-Responder Phenotype as a Tool to Evaluate Candidate Medications for Stimulant Use Disorder
Michelle R. Doyle, Lindsey N. Peng, Jianjing Cao, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 384, Iss. 3, pp. 353-362
Open Access | Times Cited: 4
Lorcaserin: Worthy of Further Insights? Results from Recent Research
Marianna Mazza, Georgios D. Kotzalidis, Giuseppe Marano, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 3, pp. 278-283
Closed Access | Times Cited: 4
Effects of naltrexone on amphetamine choice in rhesus monkeys and rats.
Hannah L. Robinson, Megan J. Moerke, Matthew L. Banks, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 6, pp. 1080-1091
Open Access | Times Cited: 4
Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders
Maleesha Ubhayarathna, Christopher J. Langmead, Natalie Diepenhorst, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 22, pp. 4414-4429
Open Access | Times Cited: 4
Epigenetics and substance use disorders: translational aspects
Gabriella M. Silva, Peter J. Hamilton
Elsevier eBooks (2024), pp. 353-378
Closed Access | Times Cited: 1
Interactions between lorcaserin and opioids: Ventilation and food-versus-drug choice
David R. Maguire
Pharmacology Biochemistry and Behavior (2023) Vol. 234, pp. 173673-173673
Open Access | Times Cited: 3
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial
Frances R. Levin, John J. Mariani, Martina Pavlicová, et al.
Drug and Alcohol Dependence (2021) Vol. 219, pp. 108482-108482
Open Access | Times Cited: 7
Effects of buprenorphine/lorcaserin mixtures on preference for heroin, cocaine, or saline over food using a concurrent choice procedure in rhesus monkeys
Lisa R. Gerak, Charles P. France
Drug and Alcohol Dependence (2021) Vol. 227, pp. 108991-108991
Open Access | Times Cited: 7
Neural circuits controlling choice behavior in opioid addiction
Victoria N. Chang, Jamie Peters
Neuropharmacology (2022) Vol. 226, pp. 109407-109407
Open Access | Times Cited: 5
Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats
Megan J. Moerke, S. Stevens Negus, Matthew L. Banks
Drug and Alcohol Dependence (2021) Vol. 231, pp. 109255-109255
Open Access | Times Cited: 6
Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders
Ken W. Grasing, Kim Burnell, Alok De
Behavioural Pharmacology (2022) Vol. 33, Iss. 4, pp. 238-248
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top